Review of VistaCare's first quarter operating results further convinces
Accipiter that Odyssey is acquiring VistaCare at a discount
NEW YORK, Feb. 13 /PRNewswire/ -- Accipiter Capital Management, the owner, together with its affiliates, of nearly 10% of the outstanding shares of common stock of VistaCare, Inc. (Nasdaq: VSTA), announced today that it had delivered a letter to VistaCare's Board of Directors stating that a review of VistaCare's Quarterly Report for the quarterly period ended December 31, 2007, has further convinced Accipiter that the offer by Odyssey Healthcare, Inc. (Nasdaq: ODSY) to acquire VistaCare for $8.60 per share is wholly inadequate. The letter further indicated that Accipiter was troubled by inconsistencies between VistaCare's internal analysis of the Company's restructuring and information VistaCare's management disclosed to investors. The letter calls on VistaCare's Board of Directors to explain these inconsistencies to stockholders and urges stockholders not to tender their shares in connection with the acquisition and to exercise their appraisal rights to the full extent permissible under law should the tender offer and subsequent merger be consummated.
Accipiter Capital Management and its affiliates do not intend to tender
their shares in connection with the acquisition and plan to exercise their
appraisal rights to the full extent permissible under law should the tender
offer and subsequent merger be consummated. The text of the letter from
Accipiter Capital Managem
'/>"/>
| SOURCE Accipiter Capital Management Copyright©2008 PR Newswire. All rights reserved |